The Global. Stada has announced that as planned and within the current scope of the European Union, it received on November 11 the positive opinion of the European Medicines Agency (EMA) for its teriparatide biosimilar medicine.
Industry news
The Global. Stada has announced that as planned and within the current scope of the European Union, it received on November 11 the positive opinion of the European Medicines Agency (EMA) for its teriparatide biosimilar medicine.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.